The US De­part­ment of De­fense is de­fend­ing its de­ci­sion to list WuXi AppTec as a Chi­nese mil­i­tary com­pa­ny, a des­ig­na­tion that may re­strict the man­u­fac­tur­er's...

Telix Phar­ma­ceu­ti­cals is buy­ing Ger­man ra­dioiso­tope man­u­fac­tur­er ITM Iso­tope Tech­nolo­gies Mu­nich SE for $1.65 bil­lion up­front, but some deal mile­stones hinge on a re­cent­ly re­ject­ed...

Amer­i­can trade of­fi­cials on Tues­day heard tes­ti­mo­ny for and against an in­ves­ti­ga­tion linked to Ger­many's de­clin­ing pay­ments for drugs, as EU-based phar­ma ex­ec­u­tives are push­ing...

The "most fa­vored na­tion" drug pric­ing deals that Pfiz­er and Eli Lil­ly signed with the Trump ad­min­is­tra­tion sug­gest the com­pa­nies will give the gov­ern­ment a...

Pres­i­dent Don­ald Trump on Fri­day an­nounced that all 50 states, Wash­ing­ton, DC, and Puer­to Ri­co will par­tic­i­pate in a new drug pric­ing mod­el un­der which...

The FDA has is­sued a warn­ing let­ter to com­pounder Em­pow­er Phar­ma­cy over its GLP-1 weight loss treat­ments. It’s the third warn­ing the Hous­ton-based com­pa­ny has...